Surflex-Dock 2.1: Robust Performance from Ligand Energetic Modeling, Ring Flexibility, and Knowledge-Based Search

Department of Biopharmaceutical Sciences, UCSF Cancer Research Institute, University of California-San Francisco, Box 0128, San Francisco, CA 94143-0128, USA.
Journal of Computer-Aided Molecular Design (Impact Factor: 2.99). 06/2007; 21(5):281-306. DOI: 10.1007/s10822-007-9114-2
Source: PubMed


The Surflex flexible molecular docking method has been generalized and extended in two primary areas related to the search component of docking. First, incorporation of a small-molecule force-field extends the search into Cartesian coordinates constrained by internal ligand energetics. Whereas previous versions searched only the alignment and acyclic torsional space of the ligand, the new approach supports dynamic ring flexibility and all-atom optimization of docked ligand poses. Second, knowledge of well established molecular interactions between ligand fragments and a target protein can be directly exploited to guide the search process. This offers advantages in some cases over the search strategy where ligand alignment is guided solely by a "protomol" (a pre-computed molecular representation of an idealized ligand). Results are presented on both docking accuracy and screening utility using multiple publicly available benchmark data sets that place Surflex's performance in the context of other molecular docking methods. In terms of docking accuracy, Surflex-Dock 2.1 performs as well as the best available methods. In the area of screening utility, Surflex's performance is extremely robust, and it is clearly superior to other methods within the set of cases for which comparative data are available, with roughly double the screening enrichment performance.

Full-text preview

Available from:
  • Source
    • "Builder and were then optimized using the Tripos force field for 2000 generations two times or more, until the minimized conformers of the ligand were the same. The flexible docking method, called Surflex-Dock [46], docks the ligand automatically into the ligand binding site of the receptor by using a protocol-based approach and an empirically derived scoring function [47]. The protocol is a computational representation of a putative ligand that binds to the intended binding site and is a unique and essential element of the docking algorithm [48]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: This article reports the design, synthesis and antiviral evaluation of a new series of non-nucleoside reverse transcriptase inhibitors (NNRTIs). The basic skeleton of these target 18 molecules is diarylpyrimidine featuring a substituted amino group between the pyrimidine scaffold and the aryl wing. All of the new compounds have been characterized by spectra analysis. The entire target molecules were evaluated for their in vitro anti-HIV activity with controlling group of FDA approved drugs. Most of them showed good to potent activities against wild-type (WT) HIV-1 with IC50 values in the range of 0.0175-69.21 μM. 2-(4-Cyanophenylamino)-4-(2-cyanovinylphenylhydrazonomethyl)pyrimidine (1d) displayed potent anti-HIV-1 activity against WT HIV-1 with a selectivity index (SI) of 106367 and an IC50 value of 1.75 nM, which was 47 fold lower than that of AZT. Compound 1d also showed a broad-spectrum inhibitory activity, with an IC50 value of 5.33 μM and 5.05 μM against both HIV-1 double-mutated (K103N/Y181C) strain and HIV-2 strain, respectively. The preliminary structure-activity relationship (SAR) was also investigated. The binding modes with HIV-1 RT for both the wild type and mutant type have also been discussed.
    European Journal of Medicinal Chemistry 06/2014; 82C:600-611. DOI:10.1016/j.ejmech.2014.05.059 · 3.45 Impact Factor
  • Source
    • "Currently, three docking programs are supported, Surflex [25] , AutoDock 4 [26] , and AutoDock Vina [27] . These programs implement different scoring functions and have varying computation times. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Polypharmacology, which focuses on designing drugs to target multiple receptors, has emerged as a new paradigm in drug discovery. To rationally design multi-target drugs, it is fundamental to understand protein-ligand interactions on a proteome scale. We have developed a Proteome-wide Off-target Pipeline (POP) that integrates ligand binding site analysis, protein-ligand docking, the statistical analysis of docking scores, and electrostatic potential calculations. The utility of POP is demonstrated by a case study, in which the molecular mechanism of anti-cancer effect of Nelfinavir is hypothesized. By combining structural proteome-wide off-target identification and systems biology, it is possible for us to correlate drug perturbations with clinical outcomes.
    Tsinghua Science & Technology 06/2014; 19(3):275-284. DOI:10.1109/TST.2014.6838198
  • Source
    • "To explore the possible bioactive conformations of different Akt inhibitors, the SyByl-x 1.3 interfaced with Surflex-Dock program (Jain 2007) was operated to dock all the compounds into the active site of the Akt kinase (PDB code: 3MV5). This program automatically docks ligand into the binding pocket of an enzyme/receptor protein, using protomol-based algorithm and empirically produces scoring function. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Inhibition mechanism(s) of protein kinase B/Akt1 and its consequences on related cell signaling were investigated in human neuroblastoma SH-SY5Y cells exposed to 4-hydroxy-trans-2-nonenal (4-HNE), one of the most reactive aldehyde by-products of lipid peroxidation. In silico data indicate that 4-HNE interacts with kinase domain of Akt1 with the total docking score of 6.0577 and also forms H-bond to Glu234 residue similar to highly potent Akt1 inhibitor imidazopiperidine analog 8b, in which the protonated imidazole nitrogen involves in two hydrogen bonds between Glu234 and Asp292. The strong hydrogen bonding with Glu234 and hydrophobic interactions with several residues, namely Leu156, Gly157, Val164, Ala177, Tyr229, Ala230, Met281 and Thr291, at the vicinity which is normally occupied by the ribose of ATP, appear to be the main causes of Akt1 inhibition and lead to the significant conformational change on this region of protein. Results of mutational docking prove that Glu234 plays a major role in 4-HNE-mediated Akt1 inhibition. In silico data on Akt inhibition were further validated by observing the down-regulated levels of phosphorylated (Thr308/Ser493) Akt1 as well as the altered levels of the downstream targets of pAkt, namely downregulated levels of pGSK3β (Ser9), β-catenin, Bcl2 and upregulated levels of pro-apoptotic markers, namely Bad, Bax, P(53) and caspase-9/3. The cellular fate of such pAkt inhibition was evidenced by increased reactive oxygen species, degraded nuclei, transferase dUTP nick end labeling positive cells and upregulated levels of pJNK1/2. We identified that 4-HNE-mediated Akt1 inhibition was due to the competitive inhibition of ATP by 4-HNE at the kinase domain of ATP binding sites.
    Archives of Toxicology 05/2014; 89(2). DOI:10.1007/s00204-014-1260-4 · 5.98 Impact Factor
Show more